BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/26/2020 9:59:39 AM | Browse: 631 | Download: 1206
 |
Received |
|
2020-07-04 07:14 |
|
Peer-Review Started |
|
2020-07-04 07:14 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-07-24 03:15 |
|
Revised |
|
2020-08-03 09:26 |
|
Second Decision |
|
2020-09-02 12:25 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-09-03 02:34 |
|
Articles in Press |
|
2020-09-03 02:34 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-09-17 02:10 |
|
Typeset the Manuscript |
|
2020-10-12 04:33 |
|
Publish the Manuscript Online |
|
2020-10-26 09:59 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Critical Care Medicine |
| Manuscript Type |
Retrospective Study |
| Article Title |
Predictive value of serum cystatin C for risk of mortality in severe and critically ill patients with COVID-19
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yan Li, Shuang Yang, Ding Peng, Hong-Ming Zhu, Bang-Yi Li, Xiaojiao Yang, Xue-Lian Sun and Mei Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mei Zhang, MD, Chief Physician, Professor, Department of Gastroenterology, Xuanwu Hospital of Capital Medical University, No. 45 Changchun Street, Xicheng District, Beijing 100053, China. zhang2955@sina.com |
| Key Words |
COVID-19; Cystatin C; Acute kidney injury; Renal function; Coronavirus infections; Multiple organ dysfunction syndrome |
| Core Tip |
The novel coronavirus epidemic has become a major public health event in the world. The mortality rate of severe and critical patients is high. It is very important to find an available, cheap, and sensitive biomarker to predict mortality. Cystatin C is a predictor of renal injury. We compared 101 severe and critical patients with coronavirus disease 2019 (COVID-19) in Wuhan, China, and found that patients with a cystatin C level of 0.80 mg/L or greater were at high risk of death. Therefore, cystatin C may have an important role in the prognosis of severe and critical patients with COVID-19. |
| Publish Date |
2020-10-26 09:59 |
| Citation |
Li Y, Yang S, Peng D, Zhu HM, Li BY, Yang X, Sun XL, Zhang M. Predictive value of serum cystatin C for risk of mortality in severe and critically ill patients with COVID-19. World J Clin Cases 2020; 8(20): 4726-4734 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i20/4726.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i20.4726 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
